본문 바로가기
셀리버리
메뉴
ABOUT US
PIPELINE
R&D
IR
PR
Overview
Greeting
Member
History
Partnership & Collaboration
Location
TSDT Platform
iCP-SOCS3
iCP-Parkin
CP-BMP2
CP-ΔSOCS3
iCP-Cre
iCP-RFs/Cas9
CV-14
iCP-NI
CV-16
CV-17
Overview
Publication
Intellectual Proprietary
Certification
주주게시판
대표이사 인터뷰영상
기술설명
Notice & News
Financials
Stock Information
Notice
Press Release
TV Broadcasting News
HOME
LOGIN
JOIN
PRESS RELEASE
LOGIN
JOIN
ABOUT US
Overview
Greeting
Member
History
Partnership & Collaboration
Location
PIPELINE
TSDT Platform
iCP-SOCS3
iCP-Parkin
CP-BMP2
CP-ΔSOCS3
iCP-Cre
iCP-RFs/Cas9
CV-14
iCP-NI
CV-16
CV-17
R&D
Overview
Publication
Intellectual Proprietary
Certification
IR
주주게시판
대표이사 인터뷰영상
기술설명
Notice & News
Financials
Stock Information
PR
Notice
Press Release
TV Broadcasting News
CELLIVERY
PR
Home
PR
About us
Pipeline
R&D
IR
PR
Notice
Notice
Press Release
TV Broadcasting News
NOTICE
28
2020-08
내재면역 제어 코로나19 면역치료제 iCP-NI 독성시험에서 안전성 입증